Ftse Mib
33.796,09
0,18%
DAX
17.950,72
0,25%
S&P 500
5.064,20
0,91%
NASDAQ
15.840,96
1,51%
Bitcoin
59.253,98
0,22%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adamis Pharmaceuticals Corporation (ADMP) Adamis Pharmaceuticals Corporation (ADMP) Notizie

Adamis Pharmaceuticals Corporation

ADMP
0,775063
0,00 (0,00%)
03 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/9/202322:50EDGAR2Form 8-K - Current report
07/9/202318:00GLOBEAdamis Pharmaceuticals Changes Name to DMK Pharmaceuticals..
01/9/202322:45EDGAR2Form 8-K - Current report
29/8/202322:30EDGAR2Form 8-K - Current report
21/8/202323:20EDGAR2Form 8-K - Current report
21/8/202315:15GLOBEAdamis Pharmaceuticals Reports Second Quarter 2023 Financial..
14/8/202322:38EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
10/8/202322:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/8/202319:43GLOBEAdamis Pharmaceuticals Announces Closing of $8.0 Million..
03/8/202322:59EDGAR2Form 8-K - Current report
03/8/202322:55EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
02/8/202314:30GLOBEAdamis Pharmaceuticals Announces Pricing of $8.0 Million..
02/8/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
31/7/202323:13EDGAR2Form 8-K - Current report
28/7/202323:01EDGAR2Form 8-K - Current report
28/7/202322:58EDGAR2Form S-1/A - General form for registration of securities..
28/7/202314:30GLOBEAdamis Pharmaceuticals to Fund ZIMHI® Clinical Study with..
27/7/202312:08EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
27/7/202303:17EDGAR2Form S-1/A - General form for registration of securities..
24/7/202322:20EDGAR2Form 8-K - Current report
24/7/202322:15EDGAR2Form 8-K - Current report
13/7/202322:37EDGAR2Form S-1 - General form for registration of securities under..
26/6/202313:30GLOBEAdamis Pharmaceuticals Announces NIH Grant Funding for the..
22/6/202313:30GLOBEAdamis Pharmaceuticals Participated in White House Meeting..
25/5/202322:26GLOBEAdamis Pharmaceuticals Announces Closing of the Merger with..
19/5/202318:00GLOBEAdamis Pharmaceuticals Announces Reverse Stock Split
15/5/202322:47GLOBEAdamis Pharmaceuticals Reports First Quarter 2023 Financial..
08/5/202322:05GLOBEAdamis Pharmaceuticals Schedules First Quarter 2023..
Apertura: Min: Max:
Chiusura: 0,775063

La tua Cronologia

NASDAQ
ADMP
Adamis Pharmaceuticals
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network